Literature DB >> 9037173

The interaction between Alzheimer amyloid beta(1-40) peptide and ganglioside GM1-containing membranes.

L P Choo-Smith1, W K Surewicz.   

Abstract

The interaction between Alzheimer amyloid peptide A beta(1-40) and membrane lipids was studied by circular dichroism spectroscopy under the conditions of physiologically relevant ionic strength and neutral pH. The peptide binds to the membranes containing ganglioside GM1 and upon binding undergoes a conformational transition from random coil to an ordered structure rich in beta-sheet. This interaction appears to be ganglioside-specific as no changes in A beta(1-40) conformation were found in the presence of various phospholipids or sphingomyelin. The isolated oligosaccharide moiety of the ganglioside was ineffective in inducing alterations in the secondary structure of A beta(1-40). No interaction was observed between ganglioside GM1 and the N-terminal peptide fragment A beta(1-28). Binding to the ganglioside is likely to modulate the neurotoxic and/or amyloidogenic properties of A beta(1-40).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9037173     DOI: 10.1016/s0014-5793(96)01504-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  42 in total

Review 1.  Amyloid beta peptide membrane perturbation is the basis for its biological effects.

Authors:  J N Kanfer; G Sorrentino; D S Sitar
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption.

Authors:  C M Yip; J McLaurin
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

3.  New EPR method for cellular surface characterization.

Authors:  J Strancar; M Schara; S Pecar
Journal:  J Membr Biol       Date:  2003-05-01       Impact factor: 1.843

4.  Binding of amyloid beta-peptide to ganglioside micelles is dependent on histidine-13.

Authors:  Mike P Williamson; Yu Suzuki; Nathan T Bourne; Tetsuo Asakura
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

Review 5.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

6.  Exploring the mechanism of beta-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models.

Authors:  Christopher B Cowan; Dhara A Patel; Theresa A Good
Journal:  J Theor Biol       Date:  2009-02-13       Impact factor: 2.691

7.  Packing of ganglioside-phospholipid monolayers: an x-ray diffraction and reflectivity study.

Authors:  J Majewski; T L Kuhl; K Kjaer; G S Smith
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

8.  Effects of human apolipoprotein E isoforms on the amyloid beta-protein concentration and lipid composition in brain low-density membrane domains.

Authors:  Maho Morishima-Kawashima; Xianlin Han; Yu Tanimura; Hiroki Hamanaka; Mariko Kobayashi; Takashi Sakurai; Minesuke Yokoyama; Koji Wada; Nobuyuki Nukina; Shinobu C Fujita; Yasuo Ihara
Journal:  J Neurochem       Date:  2007-05       Impact factor: 5.372

9.  GM1 inhibits amyloid beta-protein-induced cytokine release.

Authors:  T Ariga; R K Yu
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

10.  Up-and-down topological mode of amyloid beta-peptide lying on hydrophilic/hydrophobic interface of ganglioside clusters.

Authors:  Maho Utsumi; Yoshiki Yamaguchi; Hiroaki Sasakawa; Naoki Yamamoto; Katsuhiko Yanagisawa; Koichi Kato
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.